Landscapes / Companies
Almirall, S.A. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
3 in Phase 2
Drugs
6
in active trials · 10 in all
Trials
8 active
23 since 2021
Drugs6
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Eli Lilly |
Approved | 25 Apr 2027Phase 3 trial completes | ||
| How it works | An antibody | ||||
| Next date | 25 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Dermatitis, Atopic, Eczema and 2 more | ||||
| Open drug page | |||||
Microtubule inhibitor |
Approved | Jul 2027Phase 4 trial completes | |||
| Next date | Jul 2027 · Phase 4 trial completes | ||||
| Also tested for | Keratosis, Actinic | ||||
| Open drug page | |||||
— |
Phase 2 | Feb 2027Phase 2 trial completes | |||
| Next date | Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Hidradenitis Suppurativa | ||||
| Open drug page | |||||
— |
Phase 2 | 25 May 2027Phase 2 trial completes | |||
| Next date | 25 May 2027 · Phase 2 trial completes | ||||
| Also tested for | Hidradenitis Suppurativa | ||||
| Open drug page | |||||
— |
Phase 2 | 23 Jun 2027Phase 2 trial completes | |||
| Next date | 23 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Alopecia Areata | ||||
| Open drug page | |||||
— |
Phase 1 | 31 May 2027Phase 1 trial completes | |||
| Next date | 31 May 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
About
- No active trial
- KX2-391 Ointment 1%, of KX2-391 Ointment 1%, Pidotimod, Tirbanibulin ointment 1%
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021